Volume 14, Issue 10 (10-2016)                   IJRM 2016, 14(10): 625-628 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nazari L, Salehpour S, Hoseini S, Zadehmodarres S. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. IJRM 2016; 14 (10) :625-628
URL: http://ijrm.ir/article-1-700-en.html
1- Department of Obstetrics and Gynecology, Preventive Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , nazari@sbmu.ac.ir
2- Department of Obstetrics and Gynecology, Preventive Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (3347 Views)
Background: Repeated implantation failure (RIF) is a major challenge in reproductive medicine and despite several methods that have been described for management, there is little consensus on the most effective one.
Objective: This study was conducted to evaluate the effectiveness of platelet-rich plasma in improvement of pregnancy rate in RIF patients.
Materials and Methods: Twenty women with a history of RIF who were candidates for frozen-thawed embryo transfer were recruited in this study. Intrauterine infusion of 0.5 ml of platelet-rich plasma that contained platelet 4-5 times more than peripheral blood sample was performed 48 hrs before blastocyst transfer.
Results: Eighteen participants were pregnant with one early miscarriage and one molar pregnancy. Sixteen clinical pregnancies were recorded and their pregnancies are ongoing.
Conclusion: According to this study, it seems that platelet-rich plasma is effective in improvement of pregnancy outcome in RIF patients
Full-Text [PDF 97 kb]   (1014 Downloads) |   |   Full-Text (HTML)  (478 Views)  
Type of Study: Original Article |

References
1. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online 2014; 28: 14-38. [DOI:10.1016/j.rbmo.2013.08.011]
2. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet 2012; 29: 1227-1239. [DOI:10.1007/s10815-012-9861-4]
3. El-Toukhy T, Taranissi M. Towards better quality research in recurrent implantation failure: standardizing its definition is the first step. Reprod Biomed Online 2006; 12: 383-385. [DOI:10.1016/S1472-6483(10)61014-0]
4. Greco E, Bono S, Ruberti A, Lobascio AM, Greco P, Biricik A, et al. Comparative genomic hybridization selection of blastocysts for repeated implantation failure treatment: a pilot study. BioMed Res Int 2014; 2014: 457913. [DOI:10.1155/2014/457913]
5. Salehpour S, Zamaniyan M, Saharkhiz N, Zadeh modares S, Hosieni S, Seif S, et al. Does intrauterine saline infusion by intrauterine insemination (IUI) catheter as endometrial injury during IVF cycles improve pregnancy outcomes among patients with recurrent implantation failure?: An RCT. Iran J Reprod Med 2016; 14: 583-588.
6. Decleer W, Osmanagaoglu K, Devroey P. The role of oxytocin antagonists in repeated implantation-failure. Facts Views Vis Obgyn 2012; 4: 227-229.
7. Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod 2006; 21: 3036-3043. [DOI:10.1093/humrep/del305]
8. Green CJ, Fraser ST, Day ML. Insulin-like growth factor 1 increases apical fibronectin in blastocysts to increase blastocyst attachment to endometrial epithelial cells in vitro. Hum Reprod 2015; 30: 284-298. [DOI:10.1093/humrep/deu309]
9. Choi Y, Kim HR, Lim EJ, Park M, Yoon JA, Kim YS, et al. Integrative Analyses of Uterine Transcriptome and MicroRNAome Reveal Compromised LIF-STAT3 Signaling and Progesterone Response in the Endometrium of Patients with Recurrent/Repeated Implantation Failure (RIF). PloS one 2016; 11: e0157696. [DOI:10.1371/journal.pone.0157696]
10. Katzorke N, Vilella F, Ruiz M, Krussel JS, Simon C. Diagnosis of Endometrial-Factor Infertility: Current Approaches and New Avenues for Research. Geburtshilfe Frauenheilkunde 2016; 76: 699-703. [DOI:10.1055/s-0042-103752]
11. Aflatoonian N, Eftekhar M, Aflatoonian B, Rahmani E, Aflatoonian A. Surrogacy as a good option for treatment of repeated implantation failure: a case series. Iran J Reprod Med 2013; 11: 77-80.
12. Cavalcante MB, Costa Fda S, Barini R, Araujo Junior E. Granulocyte colony-stimulating factor and reproductive medicine: A review. Iran J Reprod Med 2015; 13: 195-202.
13. Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med 2015; 8: 1286-1290.
14. Garcia-Velasco JA, Acevedo B, Alvarez C, Alvarez M, Bellver J, Fontes J, et al. Strategies to manage refractory endometrium: state of the art in 2016. Reprod Biomed Online 2016; 32: 474-489. [DOI:10.1016/j.rbmo.2016.02.001]
15. Rossi LA, Molina Romoli AR, Bertona Altieri BA, Burgos Flor JA, Scordo WE, Elizondo CM. Does platelet-rich plasma decrease time to return to sports in acute muscle tear? A randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2016; .
16. Ronci C, Ferraro AS, Lanti A, Missiroli F, Sinopoli S, Del Proposto G, et al. Platelet-rich plasma as treatment for persistent ocular epithelial defects. Transfus Apher Sci 2015; 52: 300-304. [DOI:10.1016/j.transci.2014.12.027]
17. Sadabad HN, Behzadifar M, Arasteh F, Behzadifar M, Dehghan HR. Efficacy of Platelet-Rich Plasma versus Hyaluronic Acid for treatment of Knee Osteoarthritis: A systematic review and meta-analysis. Electron Physic 2016; 8: 2115-2022. [DOI:10.19082/2115]
18. Maria-Angeliki G, Alexandros-Efstratios K, Dimitris R, Konstantinos K. Platelet-rich Plasma as a Potential Treatment for Noncicatricial Alopecias. Int J Trichol 2015; 7: 54-63. [DOI:10.4103/0974-7753.160098]
19. Tejedor JC, Moro M, Merino JM, Gomez-Campdera JA, Garcia-del-Rio M, Jurado A, et al. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age. Pediatr Infect Dis J 2008; 27: 579-588. [DOI:10.1097/INF.0b013e31816b4561]
20. Gat I, Levron J, Yerushalmi G, Dor J, Brengauz M, Orvieto R. Should zygote intrafallopian transfer be offered to all patients with unexplained repeated in-vitro fertilization cycle failures? J Ovarian Res 2014; 7: 7. [DOI:10.1186/1757-2215-7-7]
21. Sak ME, Gul T, Evsen MS, Soydinc HE, Sak S, Ozler A, et al. Fibroblast growth factor-1 expression in the endometrium of patients with repeated implantation failure after in vitro fertilization. Eur Rev Med Pharmacol Sci 2013; 17: 398-402.
22. Karacan M, Ulug M, Arvas A, Cebi Z, Berberoglugil M, Batukan M, et al. Comparison of the transfer of equal numbers of blastocysts versus cleavage-stage embryos after repeated failure of in vitro fertilization cycles. J Assist Reprod Genet 2014; 31: 269-274. [DOI:10.1007/s10815-013-0146-3]
23. Granot I, Gnainsky Y, Dekel N. Endometrial inflammation and effect on implantation improvement and pregnancy outcome. Reproduction 2012; 144: 661-668. [DOI:10.1530/REP-12-0217]
24. Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 2006; 7: 185-199. [DOI:10.1038/nrg1808]
25. Yu W, Wang J, Yin J. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci 2011; 121: 176-180. [DOI:10.3109/00207454.2010.544432]
26. Borrione P, Gianfrancesco AD, Pereira MT, Pigozzi F. Platelet-rich plasma in muscle healing. Am J Physic Med Rehabilit 2010; 89: 854-861. [DOI:10.1097/PHM.0b013e3181f1c1c7]
27. Alcaraz J, Oliver A, Sanchez JM. Platelet-Rich Plasma in a Patient with Cerebral Palsy. Am J Case Reports 2015; 16: 469-472. [DOI:10.12659/AJCR.893805]
28. Patel AN, Selzman CH, Kumpati GS, McKellar SH, Bull DA. Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. J Cardiothorac Surg 2016; 11: 62. [DOI:10.1186/s13019-016-0452-9]
29. Reghini MF, Ramires Neto C, Segabinazzi LG, Castro Chaves MM, Dell'Aqua Cde P, Bussiere MC, et al. Inflammatory response in chronic degenerative endometritis mares treated with platelet-rich plasma. Theriogenology 2016; 86: 516-522. [DOI:10.1016/j.theriogenology.2016.01.029]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb